Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Terminated × Tetanus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 357 Carcinoma, Non-Small-Cell Lung 234 Prostatic Neoplasms 179 Neoplasms 170 Neoplasm Metastasis 159 Melanoma 135 Colorectal Neoplasms 130 Leukemia, Myeloid, Acute 129 Multiple Myeloma 127 Leukemia 109 Lung Neoplasms 108 Lymphoma 102 Pancreatic Neoplasms 98 Recurrence 94 Leukemia, Lymphocytic, Chronic, B-Cell 93 Lymphoma, Non-Hodgkin 92 Carcinoma, Renal Cell 89 Ovarian Neoplasms 86 Myelodysplastic Syndromes 79 Brain Neoplasms 77 Precursor Cell Lymphoblastic Leukemia-Lymphoma 74 Lymphoma, Follicular 73 Lymphoma, Large B-Cell, Diffuse 71 Glioblastoma 71 Carcinoma, Hepatocellular 66 Head and Neck Neoplasms 64 Squamous Cell Carcinoma of Head and Neck 63 Urinary Bladder Neoplasms 53 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 51 Hodgkin Disease 51

Interventions

sargramostim 1 Temozolomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡